PDCD1 and hepatocellular carcinoma: Moreover, as shown in the web of clinical trials (https://clinicaltrials.gov/), a series of clinical trials are ongoing based on DC vaccines (loaded with HCC neoantigens or virus-associated antigens) or combined PD-1 monoclonal antibodies.